Bernadette Hanna

ORCID: 0000-0001-6109-4328
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Genomics and Rare Diseases
  • RNA Research and Splicing
  • Cardiomyopathy and Myosin Studies
  • RNA modifications and cancer
  • Congenital limb and hand anomalies
  • Spacecraft and Cryogenic Technologies
  • Soft tissue tumor case studies
  • Cardiac Valve Diseases and Treatments
  • Glycosylation and Glycoproteins Research
  • Skin and Cellular Biology Research
  • Sarcoma Diagnosis and Treatment
  • Oral and Maxillofacial Pathology
  • Metabolism and Genetic Disorders
  • Developmental Biology and Gene Regulation
  • Connective tissue disorders research
  • Glycogen Storage Diseases and Myoclonus
  • Nuclear Structure and Function
  • Cellular transport and secretion
  • Tracheal and airway disorders
  • Superconducting Materials and Applications
  • Particle accelerators and beam dynamics
  • Genetic Neurodegenerative Diseases
  • Neurological disorders and treatments
  • Mitochondrial Function and Pathology
  • Protease and Inhibitor Mechanisms

Fermi National Accelerator Laboratory
2024

Westmead Hospital
2019-2022

Children's Hospital at Westmead
2021

Hunter Genetics
2016-2019

John Hunter Hospital
2016-2019

Hunter New England Local Health District
2017

Background Adenylyl cyclase 5 (ADCY5) mutations is associated with heterogenous syndromes: familial dyskinesia and facial myokymia; paroxysmal chorea dystonia; autosomal-dominant benign hereditary chorea. We provide detailed clinical data on 7 patients from six new kindreds in the ADCY5 gene, order to expand define phenotypic spectrum of mutations. Methods In patients, followed over a period 9 32 years, was sequenced by Sanger sequencing. The other 2 unrelated participated studies for...

10.1002/mds.26598 article EN cc-by Movement Disorders 2016-04-08
Adam Bournazos Lisa G. Riley Shobhana Bommireddipalli Lesley C. Adès Lauren Akesson and 95 more Mohammad Al-Shinnag Stephen I. Alexander Alison D. Archibald Shanti Balasubramaniam Yemima Berman Victoria Beshay Kirsten Boggs Jasmina Bojadzieva Natasha J. Brown Samantha J. Bryen Michael F. Buckley Belinda Chong Mark R. Davis Ruebena Dawes Martin B. Delatycki Liz Donaldson Lilian Downie Matthew Edwards Matthew Edwards Amanda Engel Lisa Ewans Fathimath Faiz Andrew Fennell Michael Field Mary‐Louise Freckmann Lyndon Gallacher Russell Gear Himanshu Goel Shuxiang Goh Linda Goodwin Bernadette Hanna James Harraway Megan Higgins Gladys Ho Bruce Hopper Ari Horton Matthew F. Hunter Aamira Huq Sarah Josephi‐Taylor Himanshu Joshi Edwin P. Kirk Emma Krzesinski Kishore R. Kumar Frances A. Lemckert Richard J. Leventer Suzanna Lindsey-Temple Sebastian Lunke Alan Ma Steven Macaskill Amali Mallawaarachchi Melanie A. Marty Justine E. Marum Hugh J. McCarthy Manoj P. Menezes Alison McLean Di Milnes Shekeeb S. Mohammad David Mowat Aram Niaz Elizabeth E. Palmer Chirag Patel Chirag Patel Dean Phelan Jason Pinner Sulekha Rajagopalan Matthew Regan Jonathan Rodgers Miriam Rodrigues Richard Roxburgh Rani Sachdev Tony Roscioli Ruvishani Samarasekera Sarah A. Sandaradura Elena Savva Tim Schindler Margit Shah Ingrid Sinnerbrink Janine Smith Richard J. Smith Amanda Springer Zornitza Stark Samuel P. Strom Carolyn M. Sue Kenneth Tan Tiong Yang Tan Esther Tantsis Michel Tchan Bryony A. Thompson Alison H. Trainer Karin van Spaendonck‐Zwarts Rebecca Walsh Linda Warwick Stephanie White Susan M. White Mark Williams

10.1016/j.gim.2021.09.001 article EN Genetics in Medicine 2021-11-30

Congenital heart disease (CHD) is the most common birth defect and brings with it significant mortality morbidity. The application of exome genome sequencing has greatly improved rate genetic diagnosis for CHD but cause in majority cases remains uncertain. It clear that genetics, as well environmental influences, play roles aetiology CHD. Here we address both these aspects causation respect to Notch signalling pathway. In our cohort, variants core pathway genes account 20% those disease, a...

10.1093/hmg/ddz270 article EN Human Molecular Genetics 2019-11-05
Rachel Austin Jaye S. Brown Sarah Casauria Evanthia O. Madelli Tessa Mattiske and 95 more Tiffany Boughtwood Alejandro Metke Andrew M. Davis Ari Horton David S. Winlaw Debjani Das Magdalena Soka Eleni Giannoulatou Emma M. Rath Eric Haan Gillian M. Blue Jitendra K. Vohra J. Atherton Karin van Spaendonck‐Zwarts Kathy Cox Leslie Burnett Mathew Wallis Matilda Haas Michael C. Quinn Nicholas Pachter Nicola Poplawski Zornitza Stark Richard D. Bagnall Robert G. Weintraub Sarah‐Jane Pantaleo Sebastian Lunke Paul De Fazio T. Thompson Paul A. James Yu‐Chen Chang Diane Fatkin Ivan Macciocca Jodie Ingles Sally L. Dunwoodie Chris Semsarian Julie McGaughran Lesley C. Adès A. Juanico Enríquez Alison McLean Renee Smyth Dimithu Alankarage Diane Fatkin James W. McNamara Magdalena Soka Morgan almog Vanessa S. Fear C. Medi Zornitza Stark Mohammad Al-Shinnag Miriam Fine Alejandro Metke Raymond W. Sy J. Atherton Keri Finlay Di Milnes Dotti Tang Rachel Austin Denisse Garza Michael R. Milward Jessica Taylor Richard D. Bagnall Eleni Giannoulatou A. Morrish Shelby Taylor Chris Barnett Laura Gongolidis Jim Morwood Michel Tchan Gillian M. Blue Belinda Gray Helen Mountain T. Thompson Simon Bodek C. A. Greer David Mowat Jordan Thorpe Kirsten Boggs Eric Haan Chai‐Ann Ng Alison H. Trainer Michael Bogwitz Mathilda Haas N. Nowak Gunjan Trivedi Tiffany Boughtwood Bernadette Hanna Noelia Nunez Martinez Giulia Valente Alessandra Bray Richard P. Harvey Monique Ohanian Karin van Spaendonck‐Zwarts Marie‐Jo Brion Janette Hayward S. S. O'Sullivan

The Australian Genomics Cardiovascular Disorders Flagship was a national multidisciplinary collaboration. It aimed to investigate the feasibility of genome sequencing (GS) and functional genomics resolve variants uncertain significance (VUS) in clinical management patients families with cardiomyopathies, primary arrhythmias, congenital heart disease (CHD).

10.1016/j.gimo.2024.101842 article EN cc-by-nc-nd Genetics in Medicine Open 2024-01-01

The Proton Improvement Plan (PIP)-II project is part of Fermilab's upgrade its proton accelerator complex, to provide a powerful, high-intensity beam the laboratory's upcoming research program. includes an 800 MeV superconducting (SC) linear (linac), with five flavours cavities and cryomodules. medium energy section linac contains two types Single Spoke Resonator (SSR) RF (SSR1 SSR2), which are interleaved strong solenoid focusing lenses. A unified design has been developed, one satisfying...

10.1016/j.supcon.2024.100110 article EN cc-by-nc-nd Superconductivity 2024-07-18
Coming Soon ...